Related Experiment Video
Updated: Aug 10, 2026

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
ANCA and IgA glomerulonephritis all in one: prognosis and complications
Pitchaphon Nissaisorakarn1, Vivette D'Agati2, Kisra Anis1
1Division of Nephrology, Department of Medicine, Jacobi Medical Center at Albert Einstein College of Medicine, Bronx, NY, USA.
Insights
This case study highlights a rare co-occurrence of IgA nephropathy and ANCA-associated glomerulonephritis. Elderly patients may benefit from reduced-dose immunosuppression to mitigate severe infectious complications.
Area of Science:
- Nephrology
- Immunology
- Internal Medicine
Background:
- Presents a complex case of a 75-year-old woman with pre-existing chronic kidney disease, hypertension, and diabetes.
- The patient exhibited acute kidney injury, nephrotic-range proteinuria, and a positive antimyeloperoxidase antibody.
Observation:
- Renal biopsy confirmed IgA nephropathy with superimposed pauci-immune ANCA-associated crescentic glomerulonephritis.
- Treatment involved pulse intravenous methylprednisolone, cyclophosphamide, and plasmapheresis.
- The patient experienced significant infectious complications, including influenza A, Rothia bacteraemia, and herpes zoster, following cyclophosphamide therapy.
Findings:
- Reviews the prevalence, treatment, and prognosis of coexistent IgA nephropathy and pauci-immune ANCA-associated crescentic glomerulonephritis.
- Suggests that reduced-dose immunosuppressive regimens may be beneficial for elderly patients.
- This approach could potentially decrease infectious complications without sacrificing treatment effectiveness.
Implications:
- Highlights the increased risk of severe infections in elderly patients undergoing immunosuppressive therapy for glomerulonephritis.
- Proposes a modified treatment strategy for older individuals with this dual kidney pathology.
- Emphasizes the need for careful patient selection and monitoring in managing rare autoimmune kidney diseases.
Abstract:
We present the case of a 75-year-old Hispanic woman with known stage 3 chronic kidney disease, long-standing hypertension and type 2 diabetes mellitus who presented with right-sided abdominal pain and acute kidney injury, nephrotic range proteinuria with positive antimyeloperoxidase antibody. A renal biopsy revealed IgA nephropathy with superimposed pauci-immune antineutrophilic cytoplasmic antibody (ANCA)-associated crescentic glomerulonephritis. The patient was treated with pulse intravenous methylprednisolone, cyclophosphamide and plasmapheresis. One week after her second dose of cyclophosphamide, she was readmitted for infectious complications including influenza A respiratory infection, Rothia bacteraemia associated with diarrhoea and herpes zoster of the trunk. In this report, we review the prevalence, treatment and prognosis of coexistent IgA nephropathy and pauci-immune ANCA-associated crescentic glomerulonephritis. We propose that a reduced-dose treatment regimen should be considered in elderly patients due to their higher risk of infectious complications. Current literature suggests that this treatment approach may reduce infectious complications without compromising therapeutic efficacy.
Related Concept Videos
Glaucoma: Overview
Angle Closure Glaucoma: Treatment
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention

